Skip to main content

Fennec Pharmaceuticals Inc.

FENC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001211583

In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 5 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $175.1M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Fennec Pharmaceuticals Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of FENC: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders4354+11
Shares12.5M13.0M+572.0K (+4.6%)
Value$119.5M$108.5M−$11.1M (−9.2%)

New holders (17)

Institutions that held Fennec Pharmaceuticals Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to FENC in Q1 2023
InstitutionSharesValue% of portfolio
AIGH Capital Management LLC162,154$1.35M0.50%
HRT Financial LP54,635$454.0K0.01%
AWM Investment Company, Inc.47,600$396.0K0.05%
Worth Venture Partners, LLC45,438$378.0K0.19%
Toronto Dominion Bank25,400$204.0K0.00%
Squarepoint Ops LLC20,393$169.7K0.00%
Janney Montgomery Scott LLC20,000$166.0K0.00%
Marshall Wace, LLP15,066$125.3K0.00%
Trellus Management Company, LLC11,861$98.7K0.16%
LMR Partners LLP11,402$94.9K0.00%
Cubist Systematic Strategies, LLC11,304$94.0K0.00%
Boothbay Fund Management, LLC10,818$90.0K0.00%
Point72 Asset Management, L.P.3,100$25.8K0.00%
Point72 Middle East FZE3,087$25.7K0.00%
State of Wyoming804$6.69K0.00%
Tucker Asset Management LLC500$4.16K0.00%
Wells Fargo & Company306$2.55K0.00%

Sold out (6)

Institutions that held Fennec Pharmaceuticals Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of FENC in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Opaleye Management Inc.272,200$2.61M
EAM Investors, LLC176,452$1.69M
Tamar Securities, LLC53,475$513.4K
Ancora Advisors, LLC12,245$118.0K
NewEdge Wealth, LLC10,000$96.0K
Simplex Trading, LLC2,921$28.0K